We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.64%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.47B
AUM Growth
–
Cap. Flow
+$3.39B
Cap. Flow
% of AUM
97.44%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
226
New
226
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alkermes
ALKS
|
+$77.4M |
| 2 |
West Pharmaceutical
WST
|
+$53.4M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$53.3M |
| 4 |
BWLD
Buffalo Wild Wings, Inc.
BWLD
|
+$50.9M |
| 5 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$49M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.13% |
| 2 | Healthcare | 19.25% |
| 3 | Consumer Discretionary | 16.24% |
| 4 | Industrials | 8.86% |
| 5 | Communication Services | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Tyler Technologies
TYL
$12.8B
| $13.7M | 0.39% |
+199,250
| New | +$12.9M |
|
102
Edwards Lifesciences
EW
$51.7B
| $13.3M | 0.38% |
+1,183,200
| New | +$14M |
|
103
Sarepta Therapeutics
SRPT
$1.77B
| $13.2M | 0.38% |
+346,840
| New | +$12.4M |
|
|
SGEN
104
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.5M | 0.36% |
+397,600
| New | +$13.9M |
|
105
Monro
MNRO
$398M
| $12.3M | 0.35% |
+255,700
| New | +$11.3M |
|
106
Bread Financial
BFH
$4.38B
| $12.2M | 0.35% |
+84,264
| New | +$11.5M |
|
107
RPC Inc
RES
$1.3B
| $12M | 0.34% |
+867,250
| New | +$11.8M |
|
108
Tennant Co
TNC
$1.26B
| $12M | 0.34% |
+247,766
| New | +$12.1M |
|
|
KEG
109
DELISTED
KEY ENERGY SERVICES INC
KEG
| $11.9M | 0.34% |
+2,005,900
| New | +$11.9M |
|
|
AZPN
110
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $11.8M | 0.34% |
+409,350
| New | +$11.8M |
|
|
IMPV
111
DELISTED
Imperva, Inc.
IMPV
| $11.8M | 0.34% |
+260,900
| New | +$10.2M |
|
|
PRFT
112
DELISTED
Perficient Inc
PRFT
| $11.6M | 0.33% |
+865,900
| New | +$10.3M |
|
113
BJ's Restaurants
BJRI
$1.48B
| $11.4M | 0.33% |
+306,500
| New | +$10.9M |
|
|
CTCT
114
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $11.3M | 0.33% |
+704,320
| New | +$10.2M |
|
|
LMNX
115
DELISTED
Luminex Corp
LMNX
| $11.3M | 0.33% |
+548,950
| New | +$9.98M |
|
|
OPLN
116
Openlane
OPLN
$4.54B
| $11.1M | 0.32% |
+1,286,654
| New | +$10.9M |
|
|
CSH
117
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $10.9M | 0.31% |
+526,756
| New | +$11.2M |
|
118
Oxford Industries
OXM
$552M
| $10.8M | 0.31% |
+172,300
| New | +$10.5M |
|
119
Ceco Environmental
CECO
$4.14B
| $10.5M | 0.3% |
+851,033
| New | +$10.3M |
|
|
BRCD
120
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $10.5M | 0.3% |
+1,815,700
| New | +$10.1M |
|
121
Vera Bradley
VRA
$98.7M
| $10.4M | 0.3% |
+479,700
| New | +$10.7M |
|
|
SAPE
122
DELISTED
SAPIENT CORP
SAPE
| $10M | 0.29% |
+769,400
| New | +$9.26M |
|
123
Monolithic Power Systems
MPWR
$68.9B
| $10M | 0.29% |
+415,650
| New | +$9.87M |
|
|
VRTU
124
DELISTED
Virtusa Corporation
VRTU
| $9.96M | 0.29% |
+449,351
| New | +$10.5M |
|
|
TIF
125
DELISTED
Tiffany & Co.
TIF
| $9.9M | 0.28% |
+135,900
| New | +$10.1M |
|
Similar funds
HBT
BC
SW
WFMPM
AG
TA
ACP
TP
Granahan Investment Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Granahan Investment Management, which disclosed 226 positions worth $3.47B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Alkermes: 2,655,410 shares worth $76.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Healthcare and Consumer Discretionary.
- Granahan Investment Management's largest Q2 2013 buy was Alkermes: 2,655,410 shares worth $76.2M.
- Granahan Investment Management's ten largest holdings make up 15% of its $3.47B portfolio in Q2 2013.
- Granahan Investment Management disclosed 226 positions in Q2 2013, its first 13F filing on record.
Based on Granahan Investment Management's 13F filing for Q2 2013, filed 5 Aug 2013.